PATENT CLAIM ANALYSIS

Application Number: 16025095
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2018-11
Patent Classification: ["530", "391100"]

Abstract:
Disclosed is an apheresis device including a solid carrier capable of being contacted with the blood or plasma flow, characterised in that the solid carrier includes one or several HTT-binding molecule(s) capable of adsorbing HTT or fragments thereof in a specific manner from plasma or blood or other HTT containing body fluids such as CSF.

Claim (Index 9):
The apheresis device according to  claim 8 , wherein the antibody is the monoclonal antibody PRR13.

Metadata:
- Claim Count in Document: 33.0
- Percentile: 95.0
- Lexical Diversity: 1.30435
- Patent Class: 530.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15323461', '15324962', '15323784', '10354246', '14774974']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7626766380199302
- 35 USC 102 Novelty (BERT): 0.6291733224332514
- Combined Prediction Score: 0.7493263064612624
- Mean Citation Score: 491.29881000000006
- Max Citation Score: 778.7587
- Similarity Product: 519.9079695765495

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test